Broadly neutralizing antibodies against influenza neuraminidase
Номер патента: EP4247495A1
Опубликовано: 27-09-2023
Автор(ы): Andrea MINOLA, Davide Corti, Elena FERRI, Elisabetta Cameroni, Gyorgy Snell, Matteo Samuele PIZZUTO
Принадлежит: HUMABS BIOMED SA, Vir Biotechnology Inc
Опубликовано: 27-09-2023
Автор(ы): Andrea MINOLA, Davide Corti, Elena FERRI, Elisabetta Cameroni, Gyorgy Snell, Matteo Samuele PIZZUTO
Принадлежит: HUMABS BIOMED SA, Vir Biotechnology Inc
Реферат: The instant disclosure provides antibodies and antigen-binding fragments thereof that can bind to an influenza virus neuraminidase (NA) and can neutralize an influenza virus infection. Also provided are polynucleotides that encode an antibody, vectors that comprise such polynucleotides, host cells that can express the antibodies, related compositions, and methods of using the herein disclosed compositions to, for example, treat or prevent an influenza infection.
Human neutralizing antibodies against sars-cov-2 spike s2 domain and uses thereof
Номер патента: US20240270828A1. Автор: Luis MARTINEZ-SOBRIDO,Michael PIEPENBRINK,Mark R. Walter,Ashlesha DESHPANDE,Jun-Gyu PARK,James KOBIE,Paul GOEPFERT,Nathan ERDMANN. Владелец: Texas Biomedical Research Institute. Дата публикации: 2024-08-15.